CD274 and cancer: These findings highlight PD‐L1 upregulation and enhanced interactions between cancer cells and T cells as immune microenvironment indicators of poor radiotherapy response, and they provide a rationale for combining PD‐1/PD‐L1 blockade with radiotherapy to overcome radiotherapy resistance.